New ultrasensitive detection technologies and techniques for use in microdosing studies

被引:22
作者
Lappin, Graham [1 ]
Wagner, Claudia C. [1 ]
Langer, Oliver [1 ,2 ]
van de Merbel, Nico [3 ]
机构
[1] Xceleron Inc, Germantown, MD USA
[2] Austrian Res Ctr GmbH ARC, Dept Radiopharmaceut & MicroPET Imaging, Seibersdorf, Austria
[3] PRA Int Early Dev Serv, Bioanalyt Lab, NL-9405 BJ Assen, Netherlands
关键词
POSITRON-EMISSION-TOMOGRAPHY; LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; MASS-SPECTROMETRY; PHARMACOKINETIC EVALUATION; DRUG DEVELOPMENT; RATS; PET; METABOLISM; DISCOVERY;
D O I
10.4155/BIO.09.40
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In a microdosing study, subpharmacologically active doses of drug are given to human volunteers at an early stage of development in order to obtain preliminary pharmacokinetic data. The very low doses of drug administered (<= 100 mu g) consequently lead to very low concentrations of drug appearing in the body and therefore highly sensitive analytical techniques are required. There are three such analytical technologies currently used in microdosing studies: PET, liquid chromatography (LC)-tandem mass spectrometry (MS/MS) and accelerator mass spectrometry (AMS). Both PET and AMS employ radioisotopic tracers. PET is an imaging technique and AMS is an extremely sensitive isotope ratio method, able to measure drug concentrations in the ag/ml range. LC-MS/MS does not require the presence of an isotopic tracer and its sensitivity is in the pg/ml range. This review examines each of these three analytical modalities in the context of performing microdosing studies.
引用
收藏
页码:357 / 366
页数:10
相关论文
共 56 条
[31]  
Lappin Graham., 2006, INT J PHARM MED, V20, P159
[32]   Using positron emission tomography to facilitate CNS drug development [J].
Lee, Chi-Ming ;
Farde, Lars .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (06) :310-316
[33]   Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man [J].
Levy, G ;
Mager, DE ;
Cheung, WK ;
Jusko, W .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) :985-994
[34]   Genotoxic hazard of radiopharmaceuticals in humans:: chemical and radiation aspects coupled to microdosing [J].
Lundqvist, H. ;
Antoni, G. ;
Langstrom, B. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (07) :641-645
[35]   A pharmacokinetic evaluation of five H1 antagonists after an oral and intravenous microdose to human subjects [J].
Madan, Ajay ;
O'Brien, Zhihong ;
Wen, Jianyun ;
O'Brien, Chris ;
Farber, Robert H. ;
Beaton, Graham ;
Crowe, Paul ;
Oosterhuis, Berend ;
Garner, R. Colin ;
Lappin, Graham ;
Bozigian, Haig P. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (03) :288-298
[36]   Intracavity optogalvanic spectroscopy.: An analytical technique for 14C analysis with subattomole sensitivity [J].
Murnick, Daniel E. ;
Dogru, Ozgur ;
Ilkmen, Erhan .
ANALYTICAL CHEMISTRY, 2008, 80 (13) :4820-4824
[37]   Microdosing assessment to evaluate pharmacokinetics and drug metabolism in rats using liquid chromatography-tandem mass spectrometry [J].
Ni, Jinsong ;
Hui, Ouyang ;
Aiello, Mauro ;
Seto, Carmai ;
Borbridge, Lisa ;
Sakuma, Takeo ;
Ellis, Robert ;
Welty, Devin ;
Acheampong, Andrew .
PHARMACEUTICAL RESEARCH, 2008, 25 (07) :1572-1582
[38]  
Niessen WMA, 2006, CHROMATOGR SCI SER, V97, P3
[39]  
Nutt Ronald, 2002, Mol Imaging Biol, V4, P11, DOI 10.1016/S1095-0397(00)00051-0
[40]  
PRAKASH C, 2007, DRUG METABOL LETT, P226